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Items for this week’s EPI Update include: 
  
• MRSA concerns provide opportunity for education  
• Cryptosporidium update  
• Child care exclusion criteria for Cryptosporidium cases  
• Enterobacter sakazakii – a rare cause of infant illness  
• Test your knowledge: Chronology of a rare disease investigation  
• Meeting announcements and training opportunities  
  
MRSA concerns provide opportunity for education 
  
CADE has received numerous calls regarding methicillin resistant 
Staphylococcus aureus (MRSA). As the public hears about cases in their area, 
people want to know what MRSA is, how it is spread and how to prevent it. Thus, 
this is an excellent time to talk to patients and the public about how bacteria can 
develop antibiotic resistance. Remind them that antibiotics are not needed for 
viral infections and of the importance of taking all of their antibiotics exactly as 
prescribed.  
  
Also, health care practitioners should educate patients with an MRSA infection 
about the actual risk of it spreading to family, friends, and co-workers, and how to 
prevent it. Remind people to wash their hands regularly, and to cover their mouth 
and nose with a tissue or their elbow when they sneeze or cough.  
  
When talking about MRSA, it is important to emphasize the difference between 
invasive MRSA infections and simple skin and soft tissue infections (SSTs). 
Infections with MRSA are considered invasive when they involve the blood, urine 
and spinal fluid. In Iowa, surveillance is only performed on invasive MRSA 
infections. Skin infections are not reportable to public health unless an outbreak 
is occurring.  
  
If they can be covered, SSTs should not prevent people from returning to work or 
school. As long as the skin lesions are adequately covered, the risk of spread to 
other people is low.  Also, these infections are more common than invasive 
infections and do not always need antibiotic treatment.  
  
  
Cryptosporidium update 
A record 553 confirmed Cryptosporidium cases have been reported in 2007. In 
addition, there have been 335 epi-linked cases (ill individuals who have not been 
tested but who are linked to confirmed cases) for a total of 888 Cryptosporidium 
cases this year. This outbreak appears to have peaked in the week after Labor 
Day. Although the number of individuals with swimming pool exposures has 
declined, the number of individuals exposed in child care settings remains high. 
For more information, visit 
www.idph.state.ia.us/adper/common/pdf/cade/crypto_report.pdf.  
  
Child care exclusion criteria for Cryptosporidium cases 
Children diagnosed with Cryptosporidium should remain out of child care and/or 
school until diarrhea resolves. We recommend that negative stool tests are not 
required for re-entry into child care facilities. The only diseases that require 
negative stool tests are E. coli 0157:H7, Salmonella typhi, and Shigella. Specific 
exclusion criteria for these diseases can be found in the EPI Manual chapters. 
For more information, visit 
www.idph.state.ia.us/idph_universalhelp/main.aspx?system=IdphEpiManual.  
  
Enterobacter sakazakii – a rare cause of infant illness 
Two infants with Enterobacter sakazakii septicemia have been recently reported. 
Enterobacter sakazakii is a gram-negative bacillus and can cause bloodstream 
and central nervous system infections. E. sakazakii kills 40 to 80 percent of 
infected infants. Premature infants are thought to be at greater risk than full term 
infants, other children, or adults. Infant infections with E. sakazakii have been 
associated with contaminated powdered infant formula, but other environmental 
sources of contamination are possible. Investigations were performed in both 
cases, but no source of infection was found. Further study of risk factors is 
needed. 
  
For more detailed information, see Bowen AB, Braden CR. Invasive Enterobacter 
sakazakii disease in infants. Emerg Infect Dis. [serial on the Internet] cited 
October 19, 2007 2006 Aug. This publication is available at 
www.cdc.gov/ncidod/EID/vol12no08/05-1509.htm.   
  
If your facility identifies Enterobacter sakazakii as a cause of invasive disease, 
please contact Judy Goddard at (800) 362-2736. 
  
Test your knowledge: Chronology of a rare disease investigation  
This is the second article in a 3-part series. 
  
Answer to: What disease do you think this infant acquired? The infant had 
intestinal botulism (formerly called infant botulism) 
  
Part II 
Shortly after being admitted to the hospital, the infant’s stool and serum were 
tested for botulism. The specimens were sent to the Centers for Disease Control 
and Prevention (CDC). The Infant Botulism Treatment and Prevention Program 
in California (the U.S. infant botulism referral center) was consulted and the 
decision was made to administer Baby BIG® (Botulism Immune Globulin 
Intravenous). The following week, laboratory tests indicated the presence of 
botulinum toxin type A produced by Clostridium botulinum.  
  
Question: What laboratory tests were performed on the stool and serum? 
(Answer will be in next week’s update) 
A.     The presence of botulism toxins 
B.     The presence of Clostridium bacteria 
  
The investigation revealed several potential sources of exposure.  
Question: Which of these are potential sources of infection for infant botulism? 
(Answer will be in next week’s update.) 
  
A.     The mother frequently made honey and peanut butter sandwiches for 
herself and her son.  
B.     The family had recently traveled to a Western U.S. state. 
C.    Workers were grating the soil surrounding the home they visited three 
weeks prior to the onset of illness. 
D.    The infant’s grandfather had given the infant a sip of lemonade. 
E.     The infant’s grandfather had also given the infant a small taste of Jell-o.  
  
Meeting announcements and training opportunities 
  
3rd Annual UHL Professional Forums  
Region 1: Nov. 14, DMACC Campus, Ankeny 
Region 2: Nov. 8, North Iowa Community College, Mason City  
Region 3: Nov. 7, Iowa Lakeside Laboratory, Milford  
Region 4: Nov. 13, Cass County Community Center, Atlantic  
Region 5: Nov. 28, Jefferson County Hospital, Fairfield  
Region 6: Nov. 27, Northeast Iowa Community College, Dubuque 
  
Vaccine University  
Next month, the Immunization Program staff will be traveling throughout 
the state to 16 sites to present the latest information regarding the Vaccine 
for Children (VFC) Program, vaccine storage and handling, and Iowa’s 
Immunization Law. This conference is designed to be of interest to 
pharmacists, nurses, certified medical assistants, medical assistants, 
office and support staff, administrative staff, medical and nursing students, 
and anyone who is responsible for vaccine storage and handling or 
administration.  
  
 This conference is offered free of charge and will include course materials 
and continuing education credits for nurses, pharmacists, and CMAs who 
are members of the American Association of Medical Assistants (AAMA).  
  
For more information, call (515) 309-3315 or visit 
www.idph.state.ia.us/adper/common/pdf/immunization/immunization_univ
ersity.pdf for location of the sites. To register online, go to 
www.trainingresources.org.   
  
Have a healthy and happy week! 
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